🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06317181
Recruiting Not applicable

Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data

NCT06317181 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2024-04-01
Last updated
2025-08-20

Condition(s) studied

Artificial IntelligenceUltrasonographyElasticity Imaging TechniquesLiver DiseasesMetastasis to Liver

Investigational drug(s) / intervention(s)

Collection of elastography dataCollection of ultrasonic raw data

Collection of elastography data: patients who are scheduled for an elastography for clinical reasons usually receive an ultrasound scan in which the b-mode images of the liver tissue are collected. In this study additional radiofrequency data is collected through a software access.

Collection of ultrasonic raw data: Patients who are transferred to the ultrasound departement due to suspicious focal lesions receive an ultrasonic investigation including the acquisition of raw data and extracting a definitive diagnose from the following clinical routine investigation, depending on the standards of the participating center

Study summary

The goal of this clinical trial is to test the performance of neuronal networks trained on ultrasonic raw Data (=radiofrequency data) for the assessment of liver diseases in patients undergoing a clinical ultrasound examination. The general feasibility is currently evaluated in a retrospective cohort.

The main questions the study aims to answer are:

* Can a neuronal network trained on RF Data perform equally good as elastography in the assessment of diffuse liver diseases?
* Can a neuronal network trained on RF Data perform better than a neuronal network trained on b-mode images in the assessment of diffuse liver diseases?
* Can a neuronal network trained on RF Data distinguish focal pathologies in the liver from healthy tissue?

To answer these questions participants with a clinically indicated fibroscan will undergo:

* a clinical elastography in Case ob suspected diffuse liver disease
* a reliable ground truth (if normal ultrasound is not sufficient e.g. contrast enhanced ultrasound, biopsy, MRI or CT) in case of focal liver diseases, depending on the standard routine of the participating center
* a clinical ultrasound examination during which b-mode images and the corresponding RF-Data sets are captured

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * scheduled for an ultrasound investigation by an independent physician * signed declaration of consent Exclusion Criteria: * smaller interventions in the same liver during the last 2 Week (for example liver biopsy) * contrast enhanced ultrasound less than a day ago * major intervention at the liver (for example partial resection)

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
University Hospital Dresden Germany Recruiting
Diakonissen Hospital Dresden Dresden Germany Recruiting
University Hospital Halle (Saale) Halle Germany Recruiting
University Hospital Leipzig Leipzig Germany Recruiting

More Technische Universität Dresden trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06317181 on ClinicalTrials.gov ↗ ← All trials in Germany